Description: Through a case study, this session at the 2004 Valuation Actuary Symposium explores the issues e.g., grouping, expenses, time period, etc. involved in determining deficiencies reserves for health products. Accounting guidance and standard industry procedures are discussed.

Description: This presentation is a panel discussion, session number 26PD, from the 2002 Valuation Actuary Symposium, held September 19-20 in Lake Buena Vista, FL. The Enron scandal is likely to result in a more transparent disclosure of balance sheet liabilities. The panelists provide a professional/legislative update and offer pragmatic tips to valuation actuaries about how to respond effectively to increased scrutiny. They discuss the Corporate Accountability Act and the increased oversight of the accounting profession that will result, and the implications for actuaries working in accounting firms. They emphasize the importance for actuaries to be aware of the higher standards of independence and the need to follow actuarial standards of practice. Discussion from participants is included.

Description: Discusses hazardous wastes and attempts to increase awareness of the enormous impact on the health insurance industry.